Back to all articles Virtual Launch: Africa Pathogen Genomics Initiative
Monday 12 October | 5:00 - 7:00 PM East Africa Time
Fri, Oct 9, 2020

Virtual Launch: Africa Pathogen Genomics Initiative Monday 12 October | 5:00 - 7:00 PM East Africa Time

                                    

The Pathogen Genomic Initiative is a US$100+ million partnership between Africa CDC and several private and non-profit organizations to facilitate the generation and use of essential next-generation sequencing information to improve public health response to COVID-19 and other disease threats, including endemic diseases such as HIV/AIDS, tuberculosis, malaria and cholera in Africa. The initiative is an integral part of the Institute for Pathogen Genomics, launched by Africa CDC in 2019, to strengthen capacity in genomic sequencing across Africa.

Africa PGI will be launched on Monday, 12 October 2020 from 5.00 to 7.00 pm Eastern Africa Time. Immediately after the launch, at 7.00 pm, there will be a press briefing to provide more information to journalists and answer their questions.

Journalists are invited to connect and attend the briefing on Monday, 12 October 2020, at 7.00 pm Eastern Africa Time.
Journalists will be allowed to ask questions directly online. If you have a question, send your name and the name of your media organization to WhatsApp # +251 945 502 310 or to the Africa CDC Media WhatsApp group and they will be taken by the moderator.
You can also ask your questions directly online by raising your hand through the zoom connection.

SPEAKERS

  1. 1.    Dr John Nkengasong, Director, Africa CDC
  2. 2.    Dr David Blazes, President, Global Health, Bill and Melinda Gates Foundation
  3. 3.     Dr Phillip Febbo, CEO, Illumina Inc. 

TO REGISTER VISIT: https://bit.ly/3lbLwv5

For more information: https://au.int/en/newsevents/20201012/press-briefing-launch-africa-pathogen-genomics-initiative


Articles

Thu, Jun 4, 2026

Edctp Fellow Awarded Wellcome Leap Grant For Tb Research

EDCTP Career Development Fellow Dr Virginie Rozot, a research officer at the South African Tuberculosis Vaccine Initiative (SATVI), has been awarded a multi‑year contract under Wellcome Leap’s Delta Tissue (∆T) programme. Her research will investigate how the human immune system responds to Mycobacterium tuberculosis in the thoracic lymph nodes, and why these responses sometimes fail, allowing the bacteria to spread to other organs. The findings are expected to inform future TB vaccine design and vaccination strategies.


Read more »

Read more
Thu, Jun 4, 2026

Applications Are Now Open For The Edctp Prizes 2027

Global Health EDCTP3 is now inviting applications for the EDCTP Prizes 2027, recognising outstanding individuals and research teams from Africa and Europe for their achievements in global health research and innovation.

 

The 2027 edition will award four prize categories, highlighting excellence in scientific leadership, collaborative team research, and gender-balanced scientific contributions. Prize winners will be announced at the EDCTP Forum 2027 in Madrid, Spain. Submissions are open until 2 September 2026.


Read more »

Read more
Featured Thu, Jun 4, 2026

Edctp Forum 2027: Calls For Abstracts, Scientific Symposia And Workshops Now Open

Global Health EDCTP3 has opened the calls for abstracts, scientific symposia and workshops for the EDCTP Forum 2027, one of the leading global health research events focused on infectious diseases in sub-Saharan Africa. The deadline for submissions is 2 September 2026 at 17:00 (Brussels time).

 

Under the theme ‘Innovating together for resilient global health', the 13th edition of the EDCTP Forum, taking place from 5-9 April 2027 in Madrid, Spain, will offer researchers, policymakers, funders and implementers the opportunity to showcase their work at a flagship global health event.

 

The Forum offers a unique platform to share research findings, build partnerships and help shape discussions on global health priorities. Currently, submissions for abstracts, scientific symposia and workshops are open.


Read more »

Read more